Brown & Brown, Inc.
72.97USD
-1.5200 (-2.04%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BRO.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 3.6B | 4.3B | 4.8B | 5.9B | 7.0B | 7.3B |
| Q1 | 904.7M | 1.1B | 1.3B | 1.4B | 1.9B | — |
| Q2 | 839.7M | 1.0B | 1.2B | 1.3B | 1.7B | — |
| Q3 | 927.6M | 1.1B | 1.2B | 1.6B | 1.8B | — |
| Q4 | 901.0M* | 1.0B* | 1.2B* | 1.6B* | 1.7B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 2.37 | 3.05 | 3.46 | 3.16 | 4.48 | 4.83 |
| Q1 | .770 | .830 | 1.02 | 1.15 | 1.06 | — |
| Q2 | .510 | .670 | .900 | .780 | .840 | — |
| Q3 | .570 | .620 | .810 | .680 | 1.08 | — |
| Q4 | .521* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| .957* |
| .739* |
| .843* |
| .939 |
| — |
Debt level and coverage